3645 results for «533»

Filter By

3645 results

Structural and valvular innovations

19 May 2026 – From EuroPCR 2026

This session highlights the latest innovations in structural and valvular cardiology, featuring novel technologies such as a new self-expandable transcatheter aortic valve for aortic stenosis treatment and a temporary atrioventricular sequential pacing system. It also discusses non-clinical testing methodologies supporting U.S. market approvals, non-invasive ultrasound therapy...

Innovations in vascular therapies

19 May 2026 – From EuroPCR 2026

Discover cutting-edge innovations in vascular therapies highlighting novel technologies such as Pulse Intravascular Lithotripsy (IVL) for calcium modification and Amplitude Vascular Systems. The session also presents drug-free restenosis control strategies via CD31 camouflage coating promoting physiological-grade healing, emphasizing emerging solutions aimed at improving vascular intervention outcomes.

Large-bore venous access and vessel closure: all you need to know

19 May 2026 – From EuroPCR 2026

This session provides a comprehensive guide to large-bore venous access and vessel closure techniques, emphasizing best practices and the advantages of ultrasound-guided suture mediated vessel closure compared to traditional figure-of-eight suture methods. It also addresses strategies to avoid and manage potential complications encountered during these procedures.

Large-bore venous access and vessel closure: all you need to know

Aortic paravalvular leak unmasked: different faces, different strategies

19 May 2026 – From EuroPCR 2026

Examine diverse clinical scenarios and management strategies for aortic paravalvular leaks (PVL), including complex percutaneous closures post-TAVI and surgical interventions. This session presents challenging cases demonstrating varied presentations and approaches such as mechanical valve loop utilization, highlighting the complexities and tailored solutions required for successful PVL...

STRIVE: intracoronary low-dose recombinant tissue plasminogen activator in primary PCI for STEMI and large thrombus burden

25 Oct 2025

Elad Asher provides his take on the STRIVE study presented by Shamir R. Mehta at TCT 2025, in San Francisco.

Elad Asher

Author

Elad Asher
STRIVE: intracoronary low-dose recombinant tissue plasminogen activator in primary PCI for STEMI and large thrombus burden
Didn’t find what you were looking for?